# Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation

**Authors:** Meng Zhu, Yuepeng Liu, Yumin Jia, Lixin Ren, Shuhui An, Yaxuan Wang

PMC · DOI: 10.1080/15384047.2026.2615418 · Cancer Biology & Therapy · 2026-01-14

## TL;DR

Jujuboside A fights bladder cancer by blocking ATP1A2, which disrupts energy metabolism and triggers cell death.

## Contribution

This study reveals ATP1A2 as a key target of jujuboside A in bladder cancer, linking it to mitochondrial energy metabolism and apoptosis.

## Key findings

- ATP1A2 overexpression promotes bladder cancer cell survival and energy metabolism.
- Jujuboside A inhibits ATP1A2, reducing cancer cell viability and disrupting mitochondrial metabolism.
- ATP1A2 knockdown reverses the anti-cancer effects of jujuboside A.

## Abstract

Conventional treatments for bladder cancer exhibit various limitations. Therefore, natural products, such as jujuboside A (JuA), have been explored for their multi-target effects and low toxicity. However, the specific effects of JuA in bladder cancer remain unclear.

To determine whether JuA affects mitochondrial energy metabolism and apoptosis in bladder cancer cells by regulating the ATPase Na+/K+ transporting subunit alpha 2 (ATP1A2) expression.

Differentially expressed genes (DEGs) in bladder cancer were analyzed using the GSE133624 dataset. ATP1A2 overexpression and knockdown bladder cancer cell models were constructed. Cell phenotypes and markers related to apoptosis and mitochondrial energy metabolism were assessed. Moreover, targeting effects of JuA were investigated.

Interleukin (IL)-6, ATP1A2, and hydroxysteroid 11-beta dehydrogenase 1 were identified as potential JuA targets, with ATP1A2 being the main target. ATP1A2 overexpression enhanced the viability and inhibited the apoptosis of bladder cancer cells and promoted mitochondrial energy metabolism in vitro, whereas ATP1A2 knockdown had the opposite effects. JuA decreased cell viability, inhibited ATP1A2 expression, and disrupted mitochondrial energy metabolism. These anticancer effects of JuA were reversed by ATP1A2 overexpression.

This study elucidated the molecular mechanism by which JuA regulates mitochondrial energy metabolism and induces apoptosis in bladder cancer cells through targeted inhibition of ATP1A2. These findings reveal the crucial role of ATP1A2 in the energy metabolism and survival of bladder cancer cells, providing a new molecular perspective for a deeper understanding of the pathological mechanisms of bladder cancer.

## Linked entities

- **Genes:** ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2) [NCBI Gene 477], IL6 (interleukin 6) [NCBI Gene 3569]
- **Chemicals:** jujuboside A (PubChem CID 171446)
- **Diseases:** bladder cancer (MONDO:0004986)

## Full-text entities

- **Genes:** HSD11B1 (hydroxysteroid 11-beta dehydrogenase 1) [NCBI Gene 3290] {aka 11-DH, 11-beta-HSD1, CORTRD2, HDL, HSD11, HSD11B}, ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2) [NCBI Gene 477] {aka DEE98, FARIMPD, FHM2, MHP2}
- **Diseases:** bladder cancer (MESH:D001749), toxicity (MESH:D064420)
- **Chemicals:** JuA (MESH:C087808)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12818801/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12818801/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12818801/full.md

---
Source: https://tomesphere.com/paper/PMC12818801